EMBA Medical™ Limited Cleared to Market Hourglass™ Peripheral Embolization Plug in New Zealand
Clinical Study Results for First Over-the-Wire Embolic Device Also Released
EMBA Medical™ Limited announced today that the company may now market its revolutionary peripheral embolization device in New Zealand due to the successful completion of the WAND (Web Assisted Notification of Devices) notification. In addition, the company announced completion of enrollment and release of 30-day follow-up data for the 10 patient EMBA Peripheral Embolization Device (EPED) Study conducted at Auckland Hospital.
EMBA Medical™ Limited completed the notification for the device, known as the Hourglass™ Peripheral Embolization Plug, through the New Zealand WAND database in conjunction with in-country sponsor Emergo on September 21, 2015.